Skip to content
OpenCapital
Get started

Cyclerion Therapeutics CYCN Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$875.0KDiluted EPS-$0.30

Next report

Aug 4, 2026 (In 3 weeks)
Revenue estimate$1.5M
EPS estimate-$7.10

Versus estimates

Revenue

Q4 2025$100.0KIn lineQ1 2024$100.0KIn line
Q3 2025$875.0K
Q2 2025$93.0KQ1 2025$81.0K

Diluted EPS

Q1 2026-$0.76Beat by $16.44Q4 2025-$0.19Beat by $0.19Q1 2024-$0.38In line
Q3 2025-$0.30
Q2 2025-$0.11Q1 2025-$0.56

Ask the moment Cyclerion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cyclerion Therapeutics report Q3 2025 earnings?
Cyclerion Therapeutics (CYCN) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Cyclerion Therapeutics's Q3 2025 revenue and EPS?
Cyclerion Therapeutics reported revenue of $875.0K and diluted EPS of $-0.30 for Q3 2025.
How did Cyclerion Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 351.0% from $194.0K a year earlier and diluted EPS declined 3.4% from $-0.29.
Where can I find Cyclerion Therapeutics's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001193125-25-277749) directly on SEC EDGAR. The filing index links above go to sec.gov.